|
1.
|
Kato N, Sasou S and Motoyama T: Expression
of hepatocyte nuclear factor-1β (HNF-1β) in clear cell tumors and
endometriosis of the ovary. Mod Pathol. 19:83–89. 2006.
|
|
2.
|
Kobayashi H, Yamada Y, Kanayama S,
Furukawa N, Noguchi T, Haruta S, Yoshida S, Sakata M, Sado T and Oi
H: The role of hepatocyte nuclear factor-1beta in the pathogenesis
of clear cell carcinoma of the ovary. Int J Gynecol Cancer.
19:471–479. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Yamada Y, Shigetomi H, Onogi A, Haruta S,
Kawaguchi R, Yoshida S, Furukawa N, Nagai A, Tanase Y, Tsunemi T,
Oi H and Kobayashi H: Redox-active iron-induced oxidative stress in
the pathogenesis of clear cell carcinoma of the ovary. Int J
Gynecol Cancer. 21:1200–1207. 2011.PubMed/NCBI
|
|
4.
|
Shigetomi H, Higashiura Y, Kajihara H and
Kobayashi H: A potential link of oxidative stress and cell cycle
regulation for development of endometriosis. Gynecol Endocrinol.
May 17–2012.(Epub ahead of print).
|
|
5.
|
Yoshioka K, Kunitomo M, Yanai K, Shimizu
H, Nakasono S, Negishi T and Dateki M: Hepatocyte nuclear factor 1β
induced by chemical stress accelerates cell proliferation and
increases genomic instability in mouse liver. J Recept Signal
Transduct Res. 31:132–138. 2011.
|
|
6.
|
Verdeguer F, Le Corre S, Fischer E,
Callens C, Garbay S, Doyen A, Igarashi P, Terzi F and Pontoglio M:
A mitotic transcriptional switch in polycystic kidney disease. Nat
Med. 16:106–110. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Ogata K, Shimamura Y, Hamada K, Hisa M,
Bun M, Okada N, Inoue K, Taniguchi Y, Ishihara M, Kagawa T, Horino
T, Fujimoto S and Terada Y: Upregulation of HNF-1β during
experimental acute kidney injury plays a crucial role in renal
tubule regeneration. Am J Physiol Renal Physiol. 303:F689–F699.
2012.
|
|
8.
|
Ishimoto T, Nagano O, Yae T, Tamada M,
Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H, Masuko T,
Shimizu T, Ishikawa T, Kai K, Takahashi E, Imamura Y, Baba Y,
Ohmura M, Suematsu M, Baba H and Saya H: CD44 variant regulates
redox status in cancer cells by stabilizing the xCT subunit of
system xc(−) and thereby promotes tumor growth. Cancer Cell.
19:387–400. 2011.PubMed/NCBI
|
|
9.
|
Jang Bl, Li Y, Graham DY and Cen P: The
role of CD44 in the pathogenesis, diagnosis, and therapy of gastric
cancer. Gut Liver. 5:397–405. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Lu D, Tawfik O, Pantazis C, Hobart W,
Chapman J and Iczkowski K: Altered expression of CD44 and variant
isoforms in human adenocarcinoma of the endocervix during
progression. Gynecol Oncol. 75:84–90. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Koyama S, Maruyama T and Adachi S:
Expression of epidermal growth factor receptor and CD44 splicing
variants sharing exons 6 and 9 on gastric and esophageal
carcinomas: a two-color flow-cytometric analysis. J Cancer Res Clin
Oncol. 125:47–54. 1999. View Article : Google Scholar
|
|
12.
|
Seki K, Yamaguchi A, Goi T, Nakagawara G,
Matsukawa S, Urano T and Furukawa K: Inhibition of liver metastasis
formation by anti-CD44 variant exon 9 monoclonal antibody. Int J
Oncol. 11:1257–1261. 1997.PubMed/NCBI
|
|
13.
|
Omara-Opyene AL, Qiu J, Shah GV and
Iczkowski KA: Prostate cancer invasion is influenced more by
expression of a CD44 isoform including variant 9 than by Muc18. Lab
Invest. 84:894–907. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Goi T, Koneri K, Katayama K, Hirose K and
Yamaguchi A: Evaluation of clinicopathological factors and the
correlation between the adhesion molecule CD44 variant 9 expression
and pulmonary metastases from colorectal cancers. Int Surg.
87:130–136. 2002.PubMed/NCBI
|
|
15.
|
Okano K, Shimoda T and Matsumura Y:
Clinicopathologic and immunohistochemical study of early colorectal
cancer with liver metastases. J Gastroenterol. 34:334–340. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Rodríguez-Rodríguez L, Sancho-Torres I,
Leakey P, Gibbon DG, Comerci JT, Ludlow JW and Mesonero C: CD44
splice variant expression in clear cell carcinoma of the ovary.
Gynecol Oncol. 71:223–229. 1998.PubMed/NCBI
|
|
17.
|
Eisterer W, Bechter O, Hilbe W, van Driel
M, Lokhorst HM, Thaler J, Bloem AC, Günthert U and Stauder R: CD44
isoforms are differentially regulated in plasma cell dyscrasias and
CD44v9 represents a new independent prognostic parameter in
multiple myeloma. Leuk Res. 25:1051–1057. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Akisik E, Bavbek S and Dalay N: CD44
variant exons in leukemia and lymphoma. Pathol Oncol Res. 8:36–40.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Mielgo A, van Driel M, Bloem A, Landmann L
and Günthert U: A novel antiapoptotic mechanism based on
interference of Fas signaling by CD44 variant isoforms. Cell Death
Differ. 13:465–477. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Echiburú-Chau C, Roy D and Calaf GM:
Metastatic suppressor CD44 is related with oxidative stress in
breast cancer cell lines. Int J Oncol. 39:1481–1489.
2011.PubMed/NCBI
|
|
21.
|
Sato S, Miyauchi M, Takekoshi T, Zhao M,
Kudo Y, Ogawa I, Kitagawa S, Fujita M and Takata T: Reduced
expression of CD44 variant 9 is related to lymph node metastasis
and poor survival in squamous cell carcinoma of tongue. Oral Oncol.
36:545–549. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Kahara N, Ozaki T, Doi T, Nishida K, Kawai
A, Shibahara M and Inoue H: CD44 expression in soft tissue
sarcomas. Virchows Arch. 436:574–578. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Imam H, Eriksson B and Oberg K: Expression
of CD44 variant isoforms and association to the benign form of
endocrine pancreatic tumours. Ann Oncol. 11:295–300. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Shimabukuro K, Toyama-Sorimachi N, Ozaki
Y, Goi T, Furukawa K, Miyasaka M and Aso T: The expression patterns
of standard and variant CD44 molecules in normal uterine cervix and
cervical cancer. Gynecol Oncol. 64:26–34. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Wang SJ and Bourguignon LY: Role of
hyaluronan-mediated CD44 signaling in head and neck squamous cell
carcinoma progression and chemoresistance. Am J Pathol.
178:956–963. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Kozlova I, Ruusala A, Voytyuk O, Skandalis
SS and Heldin P: IQGAP1 regulates hyaluronan-mediated fibroblast
motility and proliferation. Cell Signal. 24:1856–1862. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Ohta S, Misawa A, Fukaya R, Inoue S,
Kanemura Y, Okano H, Kawakami Y and Toda M: Macrophage migration
inhibitory factor (MIF) promotes cell survival and proliferation of
neural stem/progenitor cells. J Cell Sci. 125:3210–3220. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Zaytseva YY, Rychahou PG, Gulhati P,
Elliott VA, Mustain WC, O’Connor K, Morris AJ, Sunkara M, Weiss HL,
Lee EY and Evers BM: Inhibition of fatty acid synthase attenuates
CD44-associated signaling and reduces metastasis in colorectal
cancer. Cancer Res. 72:1504–1517. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Li J, Zha XM, Wang R, Li XD, Xu B, Xu YJ
and Yin YM: Regulation of CD44 expression by tumor necrosis
factor-α and its potential role in breast cancer cell migration.
Biomed Pharmacother. 66:144–150. 2012.
|
|
30.
|
Darzynkiewicz Z and Balazs EA: Genome
integrity, stem cells and hyaluronan. Aging (Albany NY). 4:78–88.
2012.PubMed/NCBI
|
|
31.
|
Pauloin T, Dutot M, Warnet JM and Rat P:
In vitro modulation of preservative toxicity: high molecular weight
hyaluronan decreases apoptosis and oxidative stress induced by
benzalkonium chloride. Eur J Pharm Sci. 34:263–273. 2008.
View Article : Google Scholar
|
|
32.
|
Zhao H, Tanaka T, Mitlitski V, Heeter J,
Balazs EA and Darzynkiewicz Z: Protective effect of hyaluronate on
oxidative DNA damage in WI-38 and A549 cells. Int J Oncol.
32:1159–1167. 2008.PubMed/NCBI
|
|
33.
|
Witz CA, Allsup KT, Montoya-Rodriguez IA,
Vaughan SL, Centonze VE and Schenken RS: Pathogenesis of
endometriosis - current research. Hum Fertil (Camb). 6:34–40. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Ketola K, Hilvo M, Hyötyläinen T, Vuoristo
A, Ruskeepää AL, Orešič M, Kallioniemi O and Iljin K: Salinomycin
inhibits prostate cancer growth and migration via induction of
oxidative stress. Br J Cancer. 106:99–106. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Leir SH, Baker JE, Holgate ST and Lackie
PM: Increased CD44 expression in human bronchial epithelial repair
after damage or plating at low cell densities. Am J Physiol Lung
Cell Mol Physiol. 278:L1129–L1137. 2000.PubMed/NCBI
|
|
36.
|
Daraï E, Leblanc M, Walker-Combrouze F,
Bringuier AF, Madelenat P and Scoazec JY: Expression of cadherins
and CD44 isoforms in ovarian endometrial cysts. Hum Reprod.
13:1346–1352. 1998.PubMed/NCBI
|
